Pharma Bio Serv Company Profile (NASDAQ:PBSV)

About Pharma Bio Serv (NASDAQ:PBSV)

Pharma Bio Serv logoPharma-Bio Serv, Inc. is a compliance and technology transfer services consulting company. The Company operates through four segments: Puerto Rico technical compliance consulting, United States technical compliance consulting, Europe technical compliance consulting, and Puerto Rico microbiological and chemical laboratory testing division (Lab). The Company provides a range of compliance-related consulting services. The Company provides microbiological testing services and chemical testing services through its laboratory testing facility in Puerto Rico. The Company's technical consulting services include regulatory compliance, validation, technology transfer, engineering, project management and process support. The Company markets its services to pharmaceutical, chemical, biotechnology, medical devices, cosmetic and food industries, and allied products companies in Puerto Rico, the United States, Europe and Brazil.

Industry, Sector and Symbol:
  • Trailing P/E Ratio:
  • Foreward P/E Ratio: 6.15
  • P/E Growth:
  • Net Margins: -8.23%
  • Return on Equity: -6.08%
  • Return on Assets: -5.68%
Frequently Asked Questions for Pharma Bio Serv (NASDAQ:PBSV)

What is Pharma Bio Serv's stock symbol?

Pharma Bio Serv trades on the NASDAQ under the ticker symbol "PBSV."

How were Pharma Bio Serv's earnings last quarter?

Pharma Bio Serv Inc (NASDAQ:PBSV) issued its earnings results on Thursday, January, 29th. The company reported $0.04 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.03 by $0.01. The company had revenue of $7.14 million for the quarter, compared to analysts' expectations of $7.09 million. Pharma Bio Serv had a negative return on equity of 6.08% and a negative net margin of 8.23%. View Pharma Bio Serv's Earnings History.

When will Pharma Bio Serv make its next earnings announcement?

Pharma Bio Serv is scheduled to release their next quarterly earnings announcement on Tuesday, September, 12th 2017. View Earnings Estimates for Pharma Bio Serv.

Who are some of Pharma Bio Serv's key competitors?

Who are Pharma Bio Serv's key executives?

Pharma Bio Serv's management team includes the folowing people:

  • Elizabeth Plaza, Chairman of the Board
  • Victor Sanchez, President, Chief Executive Officer
  • Pedro J. Lasanta, Chief Financial Officer, Vice President - Finance and Administration, Secretary
  • Howard Spindel, Independent Director
  • Irving L. Wiesen, Independent Director

How do I buy Pharma Bio Serv stock?

Shares of Pharma Bio Serv can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Pharma Bio Serv's stock price today?

One share of Pharma Bio Serv stock can currently be purchased for approximately $0.80.

MarketBeat Community Rating for Pharma Bio Serv (NASDAQ PBSV)
Community Ranking:  2.1 out of 5 ( )
Outperform Votes:  3 (Vote Outperform)
Underperform Votes:  4 (Vote Underperform)
Total Votes:  7
MarketBeat's community ratings are surveys of what our community members think about Pharma Bio Serv and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Pharma Bio Serv (NASDAQ:PBSV) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Pharma Bio Serv (NASDAQ:PBSV)
No equities research coverage for this company has been tracked by


Earnings History for Pharma Bio Serv (NASDAQ:PBSV)
Earnings by Quarter for Pharma Bio Serv (NASDAQ:PBSV)
Earnings History by Quarter for Pharma Bio Serv (NASDAQ PBSV)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
9/12/2017N/AView Earnings Details
1/29/2015$0.03$0.04$7.09 million$7.14 millionViewN/AView Earnings Details
9/15/2014$0.02$0.03$7.37 million$6.84 millionViewN/AView Earnings Details
6/16/2014$0.05$0.01$7.51 million$6.58 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Pharma Bio Serv (NASDAQ:PBSV)
Current Year EPS Consensus Estimate: $0.07 EPS
Next Year EPS Consensus Estimate: $0.13 EPS


Dividend History for Pharma Bio Serv (NASDAQ:PBSV)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Pharma Bio Serv (NASDAQ:PBSV)
Insider Trades by Quarter for Pharma Bio Serv (NASDAQ:PBSV)
Insider Trades by Quarter for Pharma Bio Serv (NASDAQ:PBSV)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/11/2014Kirk Wheeler MichelDirectorSell9,170$2.06$18,890.20View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Pharma Bio Serv (NASDAQ:PBSV)
Latest Headlines for Pharma Bio Serv (NASDAQ:PBSV)
DateHeadline logoPBSV: Cash Flow Positive And Trading Below Book Value - February 1 at 2:45 PM logoPharma-Bio Serv Announces Total Net Revenues of $23.4 Million and Net Income of $1.6 Million for the Year Ended October 31, 2015 - January 29 at 5:13 PM logoPHARMA-BIO SERV, INC. Files SEC form 10-K, Annual Report - January 29 at 4:08 PM logoGeorgia Bio Deals of the Year Spotlight Financings, Acquisitions and Collaboration - January 22 at 1:00 PM logoPHARMA-BIO SERV, INC. Files SEC form 8-K, Change in Directors or Principal Officers - January 5 at 4:55 PM logoPHARMA-BIO SERV, INC. Financials - December 8 at 1:15 PM logoPHARMA-BIO SERV, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits - December 1 at 4:54 PM logoPharma-Bio Serv to Present at the LD Micro Conference on December 2, 2015 - November 24 at 4:30 PM logoPBSV Returns to Revenue Growth. Maintain Buy Rec - September 15 at 3:45 PM logoPHARMA-BIO SERV, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh - September 14 at 5:10 PM logoPharma-Bio Serv Announces Results for the Three and Nine Months Ended July 31, 2015 - September 14 at 4:30 PM logoPHARMA-BIO SERV, INC. Files SEC form 10-Q, Quarterly Report - September 14 at 4:24 PM logoPharma-Bio Serv to Present at the Sidoti Emerging Growth Conference - August 31 at 4:58 PM logoPBSV: Q2 EPS Inline, New Revenue Catalysts in Pipeline - June 16 at 1:45 PM



Pharma Bio Serv (PBSV) Chart for Sunday, July, 23, 2017

This page was last updated on 7/23/2017 by Staff